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Abstract 
Different L-prolinamides 21, prepared from L-proline and chiral β-amino alcohols are 
active bifunctional catalysts for the direct nitro-Michael addition of ketones to β-
nitrostyrenes. In particular, catalyst 21e prepared from L-proline and (1S,2R)-cis-1-
amino-2-indanol exhibits the highest catalytic performance working in polar aprotic 
solvents such as NMP especially in the presence of 20 mol% of acid additives such as 
4-nitrobenzoic acid or under microwave heating. High syn-diastereoselectivities (up to 
94% de) and good enantioselectivities (up to 80% ee) are obtained at r.t. Moreover, 
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catalyst 21e can be easily recovered and reused. ESI-MS studies are used to characterize 
the intermediates assumed for the catalytic cycle. The stereochemical control attending 
Michael addition reactions between ketones and nitrostyrenes catalyzed by prolinamide 
derivatives 21 have been investigatd using computational density functional methods. 
Transition state structures for the rate-limiting C–C bond-forming step are calculated. 
Analysis of these structures indicates that hydrogen bonding plays an important role in 
catalysis and that the energy barrier for Re-face attack to form syn-(4S,5R) products is 
lower than that for the Si-face attack leading to syn-(4R,5S) products.  
 
Introduction 
 
Organocatalytic asymmetric carbon-carbon and carbon-heteroatom bond-forming 
reactions have been extensively investigated in recent years.[1] The conjugate Michael 
addition[2] plays a particularly important role among the numerous asymmetric carbon-
carbon bond forming reactions since it represents one of the most elegant and attractive 
ways to introduce chirality into a Michael acceptor.[3] Particularly interesting and 
challenging is the asymmetric conjugate addition of a carbon nucleophile to a 
nitroalkene since it represents a very useful synthetic method for the preparation of 
chiral nitroalkanes with at least two vicinal stereogenic centers in a single step. Chiral 
nitroalkanes are valuable building blocks in organic synthesis because they can be 
transformed into a wide variety of different functional groups such as amines, ketones, 
carboxylic acids, nitrile oxides, etc.[4] Barbas,[5] and List[6] independently reported the 
first organocatalytic addition of ketones to trans-β-nitrostyrene using L-proline (1) as 
catalyst with good yields but very low enantioselectivities (0 to 23% ee). A related 
study by Enders showed a strong solvent effect in the reaction since in MeOH the 
enantioselectivity could be increased to 76% for the major syn diastereomer in the 
reaction between 3-pentanone and trans-β-nitrostyrene employing a 20 mol% of L-
proline as catalyst.[7] Since these preliminary studies, very effective catalytic systems 
(2-20)[8-26] have been developed for the asymmetric Michael reaction of ketones with 
nitroalkenes being the process generally syn-selective (Scheme 1). Best improvements 
to this reaction have been mostly achieved using pyrrolidine-based catalytic derivatives. 
However, chiral acyclic primary amines such as 10, thiourea-amine bifunctional 
catalysts such as 8, 12, 13, 16 and 17, and small dipeptides such as 9 have been also 
shown to be very effective catalyst as shown in Scheme 1 for the addition of ketones to 
trans-β-nitrostyrene. Moreover, some of these catalysts have some important features to 
emphasize such as bipyrrolidine 2, which is a very active organocatalyst for the anti-
conjugate addition of α-hydroxyketones to nitrostyrenes.[8] A similar sense of relative 
stereoinduction has been shown by chiral primary amine-thiourea catalysts 13[19] and 
17[23] developed by Tsogoeva and Jacobsen, respectively, in the conjugate addition of 
acyclic ketones to nitroolefins giving predominantly the anti Michael adducts due to the 
participation of a Z-enamine intermediate. Catalysts 4,[10b] 16,[22] 19,[25] and 20[26] are 
very effective systems to perform the Michael addition under aqueous conditions such 
as brine (catalyst 4) or neat water. On the other hand, the chiral imidazolium salt 15[21] 
performs much better than other chiral pyrrolidine catalysts in ionic liquids as reaction 
media. Furthermore, catalyst 15 and the fluorous sulfonamide 19 can be easily recycled 
by precipitation and fluorous solid-phase extraction, respectively, and reused without 
significant loss of activity and stereoselectivity.  
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Scheme 1. Enantioselective conjugate addition of ketones to trans-β-nitrostyrene 
  
 L-Prolinamide and derivatives have been shown as highly efficient catalysts for 
the direct aldol reaction of aldehydes with simple ketones in organic,[27] ionic,[28] and 
aqueous solvents.[27n],[29] This type of organocatalysts have been also demonstrated to 
promote the enantioselective α-hydroxyamination reaction of α-branched aldehydes 
with good yields and moderate enantioselectivities[30] as well as the α-selenylation of 
aldehydes[31] and ketones[31b] and the α-chlorination of aldehydes.[32]  
 The initial aim in our organocatalysis program was to design several amino 
alcohol-derived organocatalysts where the amide and hydroxyl groups were expected to 
interact via double hydrogen bonding with the nitro group of the electrophile in order to 
enhance their reactivity as depicted in Scheme 2. A transient activation of the ketone 
donor through formation of an enamine on the secondary amino group was also 
anticipated.[33] In a recent preliminary paper[34] we indeed reported that amino alcohol-
derived prolinamides 21 presumably serve as bifunctional organocatalysts for Michael 
addition reactions between 3-pentanone and β-nitrostyrenes with high levels of syn-
diastereoselectivity (up to 94%) and good enantioselectivities (up to 80% ee) working 
under room temperature conditions and with polar non-protic solvents such as NMP. 
One of the main drawbacks of these catalysts was the long reaction times required to 
completion (4 days). Herein, the full account of our studies aimed to improve the 
catalytic performance of the system and to explore the full scope and the mechanism of 
this process are described. 
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Scheme 2. L-Prolinamide-derived bifunctional organocatalysts 
  
Results and Discussion 
 Catalysts 21 were prepared in good to excellent yields from Cbz- or Fmoc-L-
proline or Cbz-4-hydroxy-L-proline and the corresponding commercially available 
chiral amines and β-amino alcohols through the reaction sequence shown in Scheme 3. 
β-Amino alcohols employed in the preparation of catalysts 21i[35] and 21n[36] were 
synthesized according to literature procedures from (1S,2R)-cis-1-amino-2-indanol and 
(1R,E)-camphorquinone-3-oxime, respectively. Very recently, Córdova has 
demonstrated that simple amides derived from primary amino acids such as alanine (see 
10 in Scheme 1) efficiently catalyze the direct enantioselective addition of ketones to 
nitrostyrenes.[16] For this reason, catalyst 23 was also prepared from Boc-L-alanine 
following the synthetic sequence shown in Scheme 4.  
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Scheme 3. Synthesis of bifunctional organocatalysts 21a-n 
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Scheme 4. Synthesis of bifunctional organocatalyst 23 
 
 We first elucidated the parameters that could play a role in the selectivity of the 
reaction. Organocatalysts (20 mol%) were then examined for their ability to mediate the 
stereoselective Michael addition between 3-pentanone (25a, 4 mmol) and trans-β-
nitrostyrene (26a, 0.4 mmol) in a typical polar protic solvent such as MeOH[37] (0.2 mL: 
0.5 mL of solvent/mmol of 26a) at r.t. to give syn- and anti-adducts 27aa  (Scheme 5, 
solvent = MeOH and Table 1). α-Methyl-L-proline (28), trans-4-hydroxy-L-proline 
(29), and trans-4-TBDMSO-L-proline (30) were also included in the study (Figure 1). 
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Scheme 5. Michael addition between 3-pentanone and trans-β-nitrostyrene 
 
Table 1. Asymmetric 1,4-addition of 3-pentanone to β-nitrostyrene. Catalyst study.[a] 
Entry Catalyst t (d) Conv. (%)[b] Dr[b],[c] Ee (%)[d] 
1 21a 2 87 92/8 39 
2 21b 1.5 96 85/15 52 
3 21c 1 >99 83/17 36 
4 21d 6 80 89/11 42 
5 21e 3 95 93/7 64 
6 ent-21e 3 99 91/9 62[e] 
7 21f 3 48 91/9 48 
8 21g 3 >99 87/13 64 
9 21h 4.5 >99 85/15 64 
10 21i 3 >99 88/12 34 
11 21j 2 >99 88/12 38 
12 21k 3 48 82/18 32 
13 21l 3 >99 92/8 53 
14 21m 2 >99 86/14 52 
15 21n 3 >99 86/14 56 
16 23 6 <5 –[f] –[f] 
17 28 4 <5 –[f] –[f] 
18 29 6 <5 –[f] –[f] 
19 30 4.5 58 81/19 38 
20 21e[g] 9 37 90/10 52 
21 21e[h] 9 98 90/10 58 
22 21e[i] 3 99 89/11 56 
[a] A mixture of the corresponding catalyst (20 mol%), 3-pentanone (4 mmol), and trans-β-nitrostyrene (0.4 mmol) 
were stirred in MeOH (0.2 mL) at r.t. for the time indicated in the Table. [b] Determined by 1H NMR and/or GC 
analysis. [c] Syn/anti ratio. [d] Ee for the syn diastereoisomer. Determined by chiral-phase HPLC analysis. [e] The 
enantiomer syn-(4R,5S)-27aa was obtained. [f] Not determined. [g] 5 mol% of 21e was used. [h] 10 mol% of 21e was 
used. [i] 15 mol% of 21e was used. 
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Figure 1. Proline-derived organocatalysts 28-30 
 
Most of L-prolinamides exhibited high catalytic activities for the reaction to give 
the syn adduct 27aa as a favored product. Prolinamides 21a and 21b, derived from 1,2-
diphenyl-2-aminoethanol, which have been successfully used in the direct aldol reaction 
of ketones with aldehydes,[27a,b,e,i,q] showed good activity with high reaction conversions 
and good diastereoselectivity, syn/anti: 92/8 and 85/15, respectively, and 
enantioselectivity 39 and 52% ee for the major diastereomer, respectively (Table 1, 
entries 1 and 2). Catalyst 21c, derived from (R)-2-phenyl-2-aminoethanol, with a 
primary alcohol unit group, showed very high catalytic activity to afford after 1 d the 
Michael adduct 27aa in high yield but with lower diastero- and enantioselectivity 
(syn/anti: 83/17, 36% ee) (Table 1, entry 3). The presence of the chiral hydroxyl moiety 
seems to be important for the selectivity of the process. This was further supported with 
catalyst 21d, derived from 2-aminophenol, which gave a 42% ee for the syn adduct after 
6 d (Table 1, entry 4). The reaction time decreased to 3 d and a noticeable increase in 
yield (95%) and enantioselectivity (64% ee) was obtained with (1S,2R)-cis-1-amino-2-
indanol-derived prolinamide 21e (Table 1, entry 5). This result demonstrated that 
increasing the conformational rigidity of the amino alcohol moiety seemed to be 
beneficial for the selectivity of the process. This was probably due to the more favored 
double hydrogen-bonding interactions of the more rigid derivative 21e with the 
electrophile. Diastereomeric catalysts 21e, 21j, 21l and 21m, showed very high catalytic 
activities in the 1,4-additon (Table 1, entries 5, 11, 13, and 14), the highest 
enantioselectivity (64% ee) being observed with prolinamide 21e. This finding indicated 
that the (1S,2R) configuration of the chiral 1-aminoindanol matched the (S)-
configuration of the L-proline to enhance the stereochemical control of the reaction. On 
the other hand, catalyst ent-21e, prepared from D-proline and (1R,2S)-cis-1-amino-2-
indanol, gave the enantiomeric (4R,5S)-syn-adduct 27aa in a 62% ee (Table 1, entry 6). 
This experiment also showed that the enantioselectivity of the process was controlled by 
the proline moiety since diastereomeric catalysts ent-21e and 21l, derived from (1R,2S)-
cis-1-amino-2-indanol and L- and D-proline, respectively, afforded the corresponding 
enantiomers of the syn adduct 27aa (Table 1, entries 6 and 13). Catalysts 21f and 21k, 
derived from L-proline and (R)- and (S)-1-aminoindane, respectively, mediated the 
formation of the Michael product 27aa in lower yields (48%) and enantioselectivities, 
48 and 32%, respectively, (Table 1, entries 7 and 12) than the corresponding 
aminoalcohol-derived prolinamides 21e, 21j, 21l, and 21m. These results and the very 
low enantioselectivity (34% ee) observed with N-methylated derivative 21i (Table 1, 
entry 10) visibly showed that the presence of the hydroxyl group and a hydrogen in the 
amido group were important for a good conversion and selectivity in the 1,4-addition. 
Catalysts 21g and 21h, derived from trans-L-4-hydroxyproline, afforded similar levels 
of enantioselection than the L-proline derivative 21e but lower diastereoselectivities 
(Table 1, entries 8 and 9). Catalysts 21l and 21n gave very similar results in terms of 
activity and enantioselectivity (Table 1, entries 13 and 15). This seemed to point to a 
negligible effect of the steric bulkiness of the amide group of the organocatalysts in the 
reaction outcome. 
Although amides derived from simple primary amino acids such as alanine have 
been shown to efficiently catalyze the direct enantioselective addition of ketones to 
nitrostyrenes,[16] L-alanine amide 24 failed to give any product in the 1,4-addition of 3-
pentanone to β-nitrostyrene under the tested reaction conditions (Table 1, entry 16). 
Proline has been previously shown to promote the Michael addition of ketones to 
nitrostyrene in MeOH as solvent.[7] In contrast, α-methyl-L-proline (28), a very efficient 
organocatalyst for the intramolecular α-alkylation of aldehydes,[38] was not effective in 
the 1,4-addition after long reaction periods (Table 1, entry 17). Similar result was 
observed when trans-4-hydroxy-L-proline (29) was used as promoter, probably due to 
solubility problems (Table 1, entry 18). trans-4-TBDMSO-L-proline (30) has been 
presented as a valid alternative to proline and proline derivatives in different 
asymmetric organocatalytic processes due to its high solubility in organic solvents.[39] 
However, the catalytic activity of 30 in the conjugate addition of 3-pentanone to 
nitrostyrene in MeOH resulted very low affording 27aa in a 58% conversion and 38% 
ee for the major syn isomer (Table 1, entry 19).  
The effect of the catalyst loading on the reaction efficiency was also evaluated 
employing 21e. The enantioselectivity of the process was in general slightly sensitive to 
the catalyst loading, affording the best results in terms of yield and selectivity with a 20 
mol% of catalyst, as routinely employed (Table 1, compare entries 5 and 20-22). As 
conclusion, the catalyst study showed prolinamide 21e as the most selective 
organocatalyst in the process. It also demonstrated that the amide and the hydroxy 
groups are certainly involved in the catalysis and stereoselection of the 1,4-addition, 
probably through hydrogen bonding interactions. 
 Encouraged by these initial results, and due to the levels of reaction efficiency 
observed with prolinamide 21e, we selected this catalyst for further studies of the direct 
asymmetric addition of ketone 25a to β-nitrostyrene 26a (Scheme 5, catalyst = 21e and 
Table 2). With respect to the nucleophile stoichiometry required for optimal results, a 
ten fold excess of ketone gave the best results (Table 2, entries 1–3). We next screened a 
range of solvents for the reaction catalyzed by prolinamide 21e (Table 2, entries 5–24). 
Bulkier polar protic alcohols such as iPrOH and tBuOH were much less effective 
affording lower conversions and selectivities (Table 2, entries 5–6). Non-polar solvents 
such as toluene slowed down the reaction to 8 d affording syn-27aa in a 56% ee (Table 
2, entry 7). Furthermore, we observed the formation of the regioisomer 31 (Figure 2) in 
very low yields (8%, GC analysis), which resulted from the Michael addition to the 
carbon in α position to the nitro group. This by-product was not observed when polar 
protic solvents were used (Table 2, compare entries 1–7). The use of CHCl3 and CH3CN 
gave similar results to MeOH with respect to diastereo- and enantioselectivity detecting 
again the formation in small amounts (5%, GC analysis) of the regioisomeric compound 
31 (Figure 2, Table 2, entries 8 and 9). The employment of protic solvents seemed then 
beneficial to avoid the formation of 31. Increasing notably the polarity of the reaction 
medium with DMF provided a noticeable increase in selectivity (76% ee), being very 
important the amount of solvent used in the process since no conversion was observed 
when 5 mL of DMF/mmol of 26a were used instead of 0.5 mL/mmol of the limiting 
reagent (Table 2, entries 10 and 11). Again small amounts (5%) of 31 were detected by 
GC. Similar ee´s were obtained for DMSO, DMAc and NMP although the best 
combination of yield, diastereo- and enantioselectivity was obtained with the latest 
solvent though employing longer reaction times (Table 2, entries 12–14). 
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Figure 2. Regioisomeric product obtained in non-protic solvents 
 
 The reaction time could be reduced from 7 to 3 d by adding the electrophile to 
the reaction mixture after stirring for 20 min the ketone and the catalyst in NMP at r.t. 
(Table 2, compare entries 14 and 15). From this point all the experiments were 
performed in this manner. The presence of water has been shown to appreciably 
accelerate and improve the stereoselectivity in different organocatalyzed processes by 
facilitating hydrogen bonding and proton transfer. When the 21e-catalyzed reaction 
between 3-pentanone and β-nitrostyrene was carried out employing anhydrous 
NMP(Table 2, entry 16), similar selectivities were observed but the 1,4-addition took 
two extra days. This showed that the presence of small amounts of water (H2O content 
in the initially employed commercial NMP: 0.05%, Table 2, entry 15) had a beneficial 
effect over the reaction rate. 
 
Table 2. Asymmetric 1,4-addition of 3-pentanone to β-nitrostyrene catalyzed by 21e. 
Reaction conditions study.[a] 
Entry Solvent t Conv (%)[b] Dr[b],[c] Ee (%)[d] 
1 MeOH 3 d 95 93/7 64 
2 MeOH[e] 5 d 62 75/25 –[f] 
3 MeOH[g] 5 d 30 75/25 –[f] 
4 MeOH[h] 7 d 64 93/7 58 
5 iPrOH 4 d 71 88/12 57 
6 tBuOH 4 d 40 90/10 53 
7 Toluene 8 d 91 (8) 91/9 56 
8 CHCl3 3 d 97 (5) 91/9 58 
9 CH3CN 7 d 95 (5) 90/10 65  
10 DMF 10 d 95 (5) 92/8 76 
11 DMF[i] 10 d <5 –[f] –[f] 
12 DMSO 4 d 90 (10) 86/14 73  
13 DMAc 7 d 70 (9) 88/12 79 
14 NMP 7 d 95 (5) 90/10 79 
15 NMP[j] 3 d 78 (9) 91/9 77 
16 NMP[k] 5 d 76 (8) 90/10 77 
17 NMP/H2O[l] 6 d 63 (5) 90/10 70 
18 NMP/H2O[m] 6 d 95 (5) 90/10 72 
19 NMP/H2O[n] 6 d 84 (5) 92/8 76 
20 NMP/MeOH[o] 3 d 95 91/9 69 
21 NMP/DMSO[p] 4 d 94 (5) 86/14 75 
22 [bmim][PF6] 3 d 90 87/13 62 
23 _ 4 d 65 87/13 60 
24 NMP[q] 2.5 h 99 90/10 72 
[a] A mixture of 21e (20 mol%), 3-pentanone (4 mmol), and trans-β-nitrostyrene (0.4 mmol) was stirred in the 
corresponding solvent (0.2 mL) at r.t. for the time indicated in the Table. [b] Determined by 1H NMR and/or GC 
analysis. In parenthesis GC yield of compound 31. [c] Syn/anti ratio. [d] Ee for the syn diastereomer. Determined by 
chiral-phase HPLC analysis. [e] 5 equiv of ketone were used. [f] Not determined. [g] 1 equiv of ketone was used. [h] 40 
equiv of ketone were used. [i] 5 mL of DMF/mmol of 26a were used. [j] 26a was added to the reaction mixture after 20 
min. [k] Anhydrous NMP was used. [l] 0.5 mL of solvent (NMP/H2O: 1/1)/mmol of 26a were used (14 equiv of H2O). 
[m] 0.75 mL of solvent (NMP/H2O: 2/1)/mmol of 26a were used (14 equiv of H2O). [n] 0.6 mL of solvent (NMP/H2O: 
5/1)/mmol of 26a were used (5 equiv of H2O). [o] 0.5 mL of solvent (NMP/MeOH: 1/1)/mmol of 26a were used. [p] 
0.5 mL of solvent (NMP/DMSO: 1/1)/mmol of 26a were used. [q] The reaction was performed under microwave 
irradiation (15 W, 48 ºC). 
 
Since we had demonstrated a dramatic solvent and concentration effect in the 
reaction scope, a deep study was then performed in NMP varying the concentration of 
the reaction and the amount of water present in the reaction. The representative results 
are collected in Table 2, entries 17–21. The study demonstrated that the best results 
were indeed obtained with the commercially available NMP (0.05% H2O) which 
represents 0.014 mmol H2O/mmol 26a (Table 2, entry 15). Other different combinations 
of solvents such as NMP/MeOH and NMP/DMSO did not improve the results obtained 
so far either (Table 2, entries 20–21) with the exception that the presence of MeOH as 
cosolvent circumvent the formation of 31 again (entry 20). We also tested the 
employment of the ionic liquid [bmim][PF6] as reaction medium, but lower diastereo- 
and enantioselectivities were obtained (Table 2, entry 22). Solventless conditions (Table 
2, entry 23) led to the formation of 27aa in a 65% conversion and 60% ee for the major 
syn isomer (syn/anti: 87/13). Finally, a very fast reaction was achieved under 
microwave irradiation (15 W, 48 ºC) still preserving good diastereo- and 
enantioselectivities (Table 2, entry 24). Then, 21e (20 mol%), NMP as solvent (0.5 
mL/mmol of 26a) at r.t. were the new established reaction conditions for the conjugate 
addition of 3-pentanone (10 mmol) to trans-β-nitrostyrene (1 mmol).[40]  
In order to further decrease the long reaction times we studied the influence of 
an acid as additive in the model reaction between 3-pentanone and trans-β-nitrostyrene 
(Table 3). It has been previously demonstrated that the presence of an acidic additive in 
the reaction results beneficial in terms of activity due to acceleration of enamine 
formation.[27n],[33],[41] Thus, we started our additive study employing substoichiometric 
amounts (20 mol%) of different organic acids (Table 3, entries 1–10). Among the 
carboxylic acids, 4-nitrobenzoic acid gave the best results in terms of rate (1 d), yield 
(full conversion) and selectivity (Table 3, compare entries 1–7). In the presence of this 
cocatalyst and using anhydrous NMP, the reaction rate and the enantioselectivity of the 
process were lower which clearly demonstrated that the water present in the employed 
commercial non-anhydrous NMP was also necessary to obtain good activities and 
selectivities when using acid as cocatalyst (Table 3, entries 5 and 6). Interestingly, the 
acid additives also avoided the formation of byproduct 31 (Figure 2). Benzenesulfonic 
acid did not promote the reaction at all (Table 3, entry 8). Both enantiomers of 2-
phenylpropionic acid were also tested with the aim of detecting a possible influence on 
the selectivity of the process of a chiral proton source. Unfortunately, no improvement 
on the selectivity was observed (Table 3, entries 9 and 10). Very recently, chiral 
Brønsted acid 1,1’-bi-(2-naphthol) has been shown to improve the enantioselectivity of 
the L-proline catalyzed direct aldol reaction when used as chiral additive through 
hydrogen bonding activation.[42] We then performed the reaction in the presence of (R)- 
or (S)-1,1’-bi-(2-naphthol) (5 mol%) anticipating a possible multicomponent chiral 
catalytic system of higher efficiency. However, very similar results were obtained in 
both cases slightly decreasing the rate and selectivity of the reaction (Table 3, entries 11 
and 12). In the absence of acid, (S)-bi-2-napthol (5 mol%) did not show any 
improvement (Table 3, compare entries 12 and 13) which indicated a negligible effect 
of this additive in the reaction scope.  
 Table 3. Asymmetric 1,4-addition of 3-pentanone to β-nitrostyrene catalyzed by 21e. 
Additive study.[a] 
Entry Additive t (d) Conv (%)[b] Dr[b],[c] Ee (%)[d] 
1 _ 3 78 91/9 77 
2 AcOH 2 97 95/5 75 
3 PhCO2H 1 75 90/10 75 
4 PhCO2H[e] 6 50 97/3 78 
5 4-NO2C6H4CO2H 1 99 95/5 78 
6 4-NO2C6H4CO2H[f] 2 97 94/6 70 
7 2,4-(NO2)2C6H3CO2H 2 84 93/7 76 
8 PhSO3H 6 <5 –[g] –[g] 
9 (R)-(–)-2-phenylpropionic acid 1 65 93/7 76 
10 (S)-(+)-2-phenylpropionic acid 1 72 93/7 74 
11 (R)-1,1’-bi-(2-naphthol)[h] 4 >99 90/10 74 
12 (S)-1,1’-bi-(2-naphthol)[i] 2 >99 93/7 76 
13 (S)-1,1’-bi-(2-naphthol)[j] 4 99 91/9 73 
[a] A mixture of catalyst 21e (20 mol%), the additive (20 mol%), and 3-pentanone (4 mmol) was stirred in NMP (0.2 
mL) for 20 min at r.t. Then, the β-nitrostyrene (0.4 mmol) was added to the mixture and the reaction was stirred at r.t. 
for the time indicated in the Table. [b] Determined by 1H NMR and/or GC analysis. [c] Syn/anti ratio. [d] Ee for the syn 
diatereoisomer. Determined by chiral-phase HPLC analysis. [e] The reaction was performed at 0ºC. [f] Anhydrous 
NMP was used as solvent. [g] Not determined. [h] 5 Mol% of (R)-Binol and 5 mol% of 4-nitrobenzoic acid were used. 
[i] 5 Mol% of (S)-Binol and 5 mol% of 4-nitrobenzoic acid were used. [j] 5 Mol% of (S)-Binol was used. 
 
 Under the established best reaction conditions [21e (20 mol%) as catalyst, 4-
nitrobenzoic acid (20 mol%) as additive and NMP as solvent at r.t.] various ketones and 
nitrostyrenes were evaluated as substrates (Scheme 6 and Table 4). The reaction 
appeared quite general with respect to the nature of the aromatic Michael acceptor. 
Generally, good yields and good diastereo- and enantioselectivities were observed. The 
introduction of electron-withdrawing or electron-donating groups on the aromatic ring 
of the nitrostyrene did not affect the enantioselectivities. Thus, 4-tolyl, 4-chloro, 4-
methoxy, and 3,5-dichlorosubstituted nitrostyrene derivatives gave compounds 27ab-
27ae in 64–83% yields, 91/9 to 97/3 diastereomeric ratios and 76 to 81% 
enantioselectivities in 1.5 d reaction time (Table 4, entries 2–5). However, in the case of 
the 2-(trifluoromethyl)phenyl derivative a 59% ee for the major diastereoisomer 
(syn/anti: 99/1) syn-27af was obtained (Table 4, entry 6). When 2-chloronitrostyrene 
was used as a Michael acceptor, the corresponding Michael adduct 27ag was obtained 
in 75% yield and 78% ee (Table 4, entry 7). In general, the syn-diastereoselectivity was 
slightly higher when electron-poor nitrostyrenes were used (Table 4, entries 5 and 6).  
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Scheme 6. Michael addition of ketones to β-nitrostyrenes 
 
Table 4. Asymmetric 1,4-addition of ketones to nitrostyrenes catalyzed by 21e.[a] 
Entry R1 R2 Ar Solvent t (d) Conv. 
(%)[b] 
No. syn/anti[c] Ee 
(%)[d] 
1 Et Me Ph NMP 1 99 (76) 27aa 95/5 78[e] 
2 Et Me 4-MeC6H4 NMP 1.5 94 (64) 27ab 91/9 76 
3 Et Me 4-ClC6H4 NMP 1.5 >99 (75) 27ac 92/8 79 
4 Et Me 4-MeOC6H4 NMP 1.5 86 (74) 27ad 93/7 81 
5 Et Me 3,5-(Cl)2C6H3 NMP 1.5 >99 (83) 27ae 97/3 78 
6 Et Me 2-CF3C6H4 NMP 1.5 >99 (75) 27af 99/1 59 
7 Et Me 2-ClC6H4 NMP 1 >99 (75) 27ag 97/3 78 
8 -(CH2)4- Ph MeCN 1 >99 (80) 27ba 90/10 65[f] 
9 Me OH Ph CH2Cl2 2 >99 (64) 27ca 65/35 41[g] 
10 Me Me Ph DMSO 1.5 >99 (80) 27da[h]  90/10 54[i] 
[a] A mixture of catalyst 21e (20 mol%), 4-nitrobenzoic acid (20 mol%), and 3-pentanone (4 mmol) were stirred in the corresponding 
solvent (0.2 mL) for 20 min at r.t. Then, the nitrostyrene (0.4 mmol) was added to the mixture and the reaction was stirred at r.t. for 
the time indicated in the Table. [b] Determined by 1H NMR and/or GC analysis over the crude reaction mixture. In brackets, isolated 
yield after flash chromatography for the mixture of diastereoisomers. [c] Determined by 1H NMR and/or GC analysis over the crude 
reaction mixture. [d] Ee for the syn diastereoisomer. Determined by chiral-phase HPLC analysis. Absolute configuration not 
determined except for 27aa. [e] Similar results were obtained with recycled 21e (88% yield, syn/anti: 91/9, 78% ee). [f] A 16% ee was 
obtained when NMP was used as solvent. [g] 35% ee for the anti isomer. [h] Syn/anti/iso: 54/6/40. [i] 5% Ee for the anti isomer; 76% ee 
for the iso isomer. 
 
Next, we examined other ketone donors in the Michael reaction with trans-β-
nitrostyrene (Scheme 6, Table 4). For each nucleophile a full solvent study was carried 
out since we observed enormous differences in reactivity and selectivity depending of 
the solvent employed.[43] In Table 4 entries (7–10) we have recovered the results under 
the optimized reaction conditions for the new ketones studied. The conjugate addition of 
cyclohexanone as a Michael donor catalyzed by 20 mol% of 21e proceeded with good 
diastereoselectivity (syn/anti: 90/10) and moderate selectivity 65% ee when using 
MeCN as solvent (Table 4, entry 8). Surprisingly, NMP led to a very low 16% ee in this 
particular case. The conjugate reaction between hydroxyacetone and nitrostyrene was 
regioselective for all the studied reaction conditions,[43] CH2Cl2 being the solvent which 
gave better results in terms of enantioselectivity. As depicted in the entry 9 of Table 4, 
the reaction was less syn-selective than previously observed giving a 65/35 syn/anti 
relationship with low enantioselectivities for both isomers (41% ee for syn-27ca and 
35% ee for anti-27ca). On the other hand, the 21e-catalyzed Michael addition of 
butanone with nitrostyrene mainly gave the iso isomer in moderate to good 
enantioselectivities[43] giving the best result in DMSO (Table 4, entry 10, Scheme 7). 
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Scheme 7. Michael addition of butanone to trans-β-nitrostyrene 
 
 It is worthy to mention that prolinamide catalyst 21e could be easily recovered 
(80% recovery) from the reaction mixture after extractive acid-base workup and reused 
after flash chromatography with similar results (Table 4, entry 1) since no loss of optical 
activity was detected in the organocatalyst { [ ]20Dα = –24.4 (c 1.0, CH2Cl2)}. 
With respect to the reaction mechanism, it is accepted that when primary or 
secondary chiral amines are used as organocatalysts, the reaction clearly involves an 
enamine pathway. The existence of the enamine intermediate I in the 21e-catalyzed 
Michael addition of 3-pentanone to β-nitrostyrene was confirmed employing the ESI-
MS method (Scheme 8, Figure 3). Under the typical reaction conditions, enamine I.H+ 
(m/z = 315.1) was detected after stirring for 20 min the organocatalyst 21e (20 mol%), 
3-pentanone (1 mmol) and 4-NO2C6H4CO2H (20 mol%) employing MeOH as solvent 
(Figure 3a). To this solution was then added trans-β-nitrostyrene (0.1 mmol) and the 
mixture was injected after 0.2 min. The formation of intermediate II (m/z = 464.3) 
(Scheme 8) was a fast reaction since it was immediately detected in the mixture by ESI-
MS (Figure 3b). This meant that enamine I attacks the electrophile probably activated 
by hydrogen bonding by the amide moiety to give intermediate II. We could also 
intercept[43] the adduct ion III.H+ (m/z 396.2, Scheme 8) formed by a reversible Michael 
addition of 21e to the electrophile. The last step of the catalytic cycle involves the 
regeneration of 21e by hydrolysis facilitated by the small amounts of water present in 
the solvent.  
 
25a
26a
N
H
O
N
H
HO
O
N
O
HN
HO NO2
Ph
N
O
HN
HOO2N
Ph
O2N
Ph O
21e
-H2O
H2O
II
ESI-MS: 464.3 [M]+
I
ESI-MS: 315.1 [M+H]+
syn-27aa
21e
Ph
N
O–
O
+
N
O
N
H
HO
III
ESI-MS: 396.2 [M+H]+
N N
O
H
O
H
A
Ph
N
O
O
 
Scheme 8. Proposed mechanism for the 21e-catalyzed Michael addition  
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Figure 3. ESI/MS-(+) spectra of the intermediates a) I.H+, b) II+ (see Scheme 8). 
 
 Figure 4 indicates the relationship between the ee value of the catalyst 21e used 
in the Michael reaction and the ee value of the Michael adduct 27aa. The observed 
linearity suggested that the active catalyst in this process is a monomeric species.[44] The 
syn-diastereoselectivity and the absolute configuration observed can be reasonably 
explained through the acyclic synclinal transition state assembly A proposed by 
Seebach,[45] assuming intramolecular hydrogen bonding (Scheme 8).  
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Figure 4. Observation of nonlinear effect of 21e with 27aa. 
 
Computational Studies: 
To explain the predominant production of (4S,5R)-syn-adduct, we have 
computationally[46] located and studied the transition states for the formation of both 
enantiomers by DFT[47] at B3LYP/6-31G* level.[48] For computational simplicity 
reasons, we have chosen the non-substituted prolinamide 32 as a model catalyst for the 
reaction between 3-pentanone 25a and 1-nitropropene 33 (Figure 5). Since the 
formation of the enamine and the final hydrolysis of the Michael addition adduct are 
fast and have no effect on the rate and stereoselectivity of the reaction,[49] we focused on 
the study of the transition states involved in the rate-limiting step, the nucleophilic 
attack of the enamines 34 to 1-nitropropene. For the calculation of the activation 
barriers of those reactions, it was also necessary to determine the energies of the 
reactant hydrogen bond complexes formed between the enamines and 1-nitropropene. 
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Figure 5. Model reaction used for the DFT computational studies. 
 
The enamine can be found in two different conformations, syn-34 and anti-34. 
For each of them, two different transition states exist for the approach of the 
nitropropene to the diastereotopical Re and Si faces of the enamine, resulting in the 
formation of four different transition states, two for each enantiomer (Figure 6). The 
two transition states arising from the anti enamine (TSA and TSB) can benefit from the 
hydrogen bonding activation with the NH and OH present in the prolinamide and our 
initial hypothesis was that this interaction might contribute to a lowering in the energy 
barriers, resulting in faster reaction rates. Meanwhile, reaction through syn enamine 
conformations would only occur in an uncatalyzed way, without the help of hydrogen 
bonding activation (TSC and TSD). We located the four possible transition states and 
found that the lowest in energy (15.0 kcal/mol) corresponds to TSA, the one that leads to 
the experimentally observed syn-(4S,5R) enantiomer. According to our initial 
hypothesis, this result shows that both NH and OH in the catalyst activate the 
nitroalkene by the concurrence of up to three hydrogen bonds, favoring the approach of 
the nitroalkene from the Re face of the anti enamine. The minor enantiomer syn-(4R,5S) 
is formed through Si approach of the nitroalkene to the anti enamine (TSB), whose 
activation energy is 16.4 kcal/mol. The difference between TSA and TSB accounts for 
1.4 kcal/mol, corresponding to a computed ≈ 10:1 selectivity (≈ 80% ee) in favor of the 
syn-(4S,5R) enantiomer. 
The other two transition states (TSC and TSD) do not show hydrogen bonding 
activation. Therefore, their activation barriers are much higher than those of their 
activated counterparts TSC>>TSA and TSD >>TSB. Interestingly, there is an inverse 
relationship between the distance of the two bond-forming carbon atoms (C1---C2) and 
the reaction rate. The fastest reaction corresponds to the earliest transition state TSA 
(δC1-C2 = 2.13 Å) and the slowest reaction to the lattest transition state TSD (δC1-C2 = 1.94 
Å). 
TSA (anti-Re): 15.0 kcal/mol TSB (anti-Si): 16.4 kcal/mol
TSC (syn-Re): 18.2 kcal/mol TSD (syn-Si): 27.6 kcal/mol
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Figure 6. Transition state geometries and activation energies for the reaction 
between 25a and 32, calculated at B3LYP/6-31G*. 
 
The reasons for the observed stereoselectivity are understandable in view of the 
hydrogen bonding differences between TSA and TSB and the data shown in Table 5. In 
both cases we can distinguish up to three hydrogen bonds (two of them strong and one 
weak) between the two oxygen atoms of the nitro group and the NH and OH in the 
prolinamide. The rigidity and steric congestion of the proline-based enamine allows for 
a clear differentiation in the strength of those interactions. In TSA, one of the oxygens of 
the nitro (O1) is able to form two strong hydrogen bonds with H-N3 (2.03 Å) and 
especially with H-O3 (1.88 Å), whereas TSB shows two relatively weaker bonds, with 
larger distances for O1---H-N3 (2.11 Å) and O2---H-O3 (2.09 Å). In both cases, there is 
a third very weak hydrogen bond with H-N3 (distances ≈ 2.5 Å), but it can be 
considered that this interaction is less important in the activation of the nitro group. 
Finally, the distances between O2---H-O3 in TSA and O1---H-O3 in TSB are too large 
(>2.7 Å) to describe them as hydrogen bonds, although they still can represent positive 
electrostatic interactions. These data suggest that the strength difference of the hydrogen 
bonds in TSA and TSB is responsible for the computed facial selectivity. Noteworthy, 
the source of the chirality in these models is only the stereogenic center at position 2 of 
the pyrrolidine ring. We have not included the chirality in the hydroxyethylamino group 
of the prolinamide. Therefore, by appropriate choice of the substituent and the matched 
relative configuration we can further modulate the stereoselectivity of the reaction.   
 
Table 5. Activation energies and interatomic distances for the transition states 
calculated at B3LYP/6-31G* level 
 TSA TSB TSC TSD 
Activation energies[a] 15.0 16.4 18.2 27.6 
Distances[b]     
C1---C2 2.129 2.095 2.012 1.945 
N1---N2 3.260 3.103 --- --- 
O1---H-N3 2.028 2.109 --- --- 
O1---H-O3 1.885 2.845 --- --- 
O2---H-N3 2.589 2.557 --- --- 
O2---H-O3 2.720 2.093 --- --- 
[a] Activation energies in kcal/mol calculated at B3LYP/6-31G*+ZPVE. [b] Distances in Å. 
 
Conclusions 
 From the studies carried out about the direct enantioselective conjugate addition 
of ketones to β-nitrostyrenes catalyzed by 1,2-amino alcohol-derived prolinamides, it 
can be concluded that these organocatalysts promote the syn-diastereo- and 
enantioselective Michael addition of ketones to nitrostyrenes in polar aprotic solvents 
such as NMP. From a wide variety of prolinamide derivatives, the best catalyst 21e, 
derived from L-proline and (1S,2R)-cis-1-amino-2-indanol, gave a diastereomeric excess 
of up to 94% and up to 80% ee of the syn adduct. High reaction rates could be achieved 
employing acid additives such as 4-nitrobenzoic acid or under microwave irradiation 
conditions. Both the amide hydrogen and the chiral hydroxyl group of the catalysts play 
an important role in the process. Furthermore, prolinamide catalysts can be recovered 
and reused. From ESI-MS experiments on the Michael reaction between 3-pentanone 
and trans-β-nitrostyrene catalyzed by 21e it was possible to characterize all the 
intermediates assumed for the catalytic cycle. Computational studies at B3LYP/6-31G* 
level have been conducted on a model reaction, confirming the initial hypothesis that 
hydrogen bonding plays a crucial role on the activation of the nitroalkene, and helps to 
discriminate between the two diastereofacial approaches. The computationally favored 
transition state TSA presents the strongest hydrogen bonds and, in accordance with the 
experimental results, leads to the observed major syn-(4S,5R) enantiomer. 
Further studies on the scope of prolinamide-derived catalysts 21 in Michael and other 
organocatalytic asymmetric C–C bond-forming reactions are currently underway. 
 
Experimental Section 
General. Melting points were obtained with a Reichert Thermovar apparatus and were 
not corrected. IR data were collected on a FTIR apparatus, Nicolet Impact 400D-FT, 
and peaks are reported in cm–1. Specific rotations were determined at 20 ºC with a 
Perkin–Elmer 341 digital polarimeter. Enantiomeric excesses were determined using a 
Shimadzu HPLC (LC-10AD pump and SPD-10a detector), JASCO HPLC (PU-2089 
Plus pump, MD-2010 Plus detector and an AS-2059 Plus automatic injector) or Agilent 
1100 Series HPLC (G1311A Quat Pump, DAD G1315B detector and an automatic 
injector). For each new compound, wavelength, solvent mixture, flow rate, column 
used, retention time and major enantiomer (in bold) are stated. NMR spectra were 
recorded on a Bruker AC-300 (300 MHz for H1 NMR and 75 MHz for 13C NMR) using 
CDCl3 as solvent and TMS as internal standard unless otherwise noted; chemical shifts 
are given in δ (ppm) and coupling constants (J) in Hz. Low-resolution electron impact 
(EI) mass spectra were obtained at 70 eV on a Shimadzu QP-5000 and Agilent 5973 
spectrometers and DIP (Direct Insertion Probe) mass spectra were obtained on a Agilent 
5973 spectrometer, fragment ions m/z with relative intensities (%) in parenthesis. 
HRMS were performed in a Finnigan MAT 95S spectrometer. ESI-MS experiments 
were carried out with an Agilent 1100 Series LC/MSD Trap “SL” mass spectrometer 
equipped with an ESI source. Analytical TLC was visualized with UV light at 254 nm. 
Thin layer chromatography was carried out on TLC aluminium sheets with silica gel 60 
F254 (Merck). For flash chromatography silica gel 60 (0.040-0.063mm) was employed in 
a Büchi Pump system (Controller C–610 y Module C–601). Microwave experiments 
were performed using a CEM DISCOVER Synthesis unit. Reactions under inert 
atmosphere (argon) were performed in oven-dried glass-ware, sealed with a rubber 
septum, using anhydrous solvents. 
Typical procedure for the synthesis of 22 and 24: To a 0 ºC solution of the 
corresponding N-protected-L-proline derivative (Scheme 3) or N-protected-L-alanine 
(8.0 mmol) (Scheme 4) and TEA (8.0 mmol) in THF (30 ml) was added dropwise ethyl 
chloroformate (8.0 mmol) for 15 min. After the solution was stirred at 0 ºC for 30 min, 
the corresponding amine (8.0 mmol) was added dropwise for 15 min. The resulting 
solution was stirred for 1 h at 0 ºC and at r.t. for another 16 h, and then refluxed for 3 h. 
After cooling down to r.t., the solution was diluted with EtOAc. After filtration and 
removal the solvent under reduced pressure, the corresponding N-protected amides 22a-
n, and 24 were obtained and used in the next step without further purification. 
Experimental procedure for the synthesis of compound 21a: Piperidine (0.56 ml, 
5.64 mmol) was added to a 0 ºC solution of Fmoc-22a (1.5 g, 2.82 mmol) in CH3CN 
(30 ml). The resulting mixture was maintained at 0 ºC for 30 min, and at r.t. fot 3 h and 
then concentrated. The crude residue was purified by recrystallization in EtOH to give 
pure 21a. 
Typical procedure for the synthesis of compounds 21b-n: Compounds Cbz-22b-n 
(1g), 5% Pd/C (0.1g, 10% weight) and MeOH (30 mL) were mixed in a 100 mL two 
necks botton flask. After stirred under hydrogen (1 atm) for 1 h, the solution was 
filtered throug a pad of celite. After removal the solvent, the resulting residue was 
purified by: recrystallization (21b, 21c, 21d, 21e, 21g, 21i, 21j, 21l, and 21m) or by 
flash chromatography (EtOAc) (21f, 21h, 21k, and 21n). 
Experimental procedure for the synthesis of compound 23. Boc-L-alanine (440 mg, 
1.25 mmol) was stirred in a 4 M hydrogen chloride solution in dioxane (5 ml) for 30 
min and then extracted with EtOAc (3 × 15 ml). The aqueous phase was treated with 
15% NaOH until pH 10 and then extracted with EtOAc (3 × 15 ml). The organic layer 
was dried over anhydrous MgSO4, filtered off and the solvent was evaporated at low 
pressure to give product 23 pure by 1H NMR.  
(2S)-N-[(1S,2R)-2-Hydroxy-1,2-diphenylethyl]pyrrolidine-2-carboxamide (21a). 
White solid; M.p. 144 ºC (EtOH); [ ]20Dα –19.5 (c 1.0, MeOH); Rf (MeOH/EtOAc: 1/1) 
0.48; IR ν (KBr) 3325, 3299 (N–H, O–H), 1687 (C=O), 1044, 1024 (C–O) cm-1; 1H 
NMR δ 1.58–1.67 (m, 2 H, CH2CH2NH), 1.75–1.85 (m, 1 H, CH2CHCO), 1.96–2.10 
(m, 1 H, CH2CHCO), 2.57 (s, 2 H, OH, NH), 2.79–2.87 (dt, J = 10.3, 6.3 Hz, 1 H, 
CH2N), 2.93–3.01 (dt, J = 10.2, 6.7 Hz, 1 H, CH2NH), 3.72–3.77 (dd, J = 9.0, 5.3 Hz, 1 
H, CHCO), 5.4 (d, J = 4.2 Hz, 1 H, CHOH), 5.25–5.29 (dd, J = 8.6, 4.0 Hz, 1 H, 
PhCHNH), 6.98–7.26 (m, 10 H, ArH), 8.43–8.46 (d, J = 8.4 Hz, 1 H, NHCO) ppm; 13C 
NMR δ 26.1 (CH2CH2NH), 30.5 (CH2CHCO), 47.2 (CH2NH), 59.1 (NCHPh), 60.5 
(CHCO), 77.5 (OCHPh), 126.7, 127.48, 127.54, 127.6, 127.8, 128.1 (ArCH), 137.5, 
139.7 (ArC), 175.4 (C=O) ppm; MS m/z 292 [M+ – H2O, 4%], 290 (28), 201 (27), 194 
(20), 184 (34), 183 (53), 181 (10), 180 (54), 179 (13), 178 (12), 165 (11), 156 (13), 90 
(13), 89 (19), 77 (12), 70 (100); HRMS calcd. for C19H22N2O2 [M+] 310.1681, [M+–
H2O] 292.1565, found 292.1546. 
(2S)-N-[(1R,2S)-2-Hydroxy-1,2-diphenylethyl]pyrrolidine-2-carboxamide (21b). 
White solid; M.p. 70 ºC (EtOAc/MeOH, ∆); [ ]20Dα –23.8 (c 0.52, EtOH); Rf 
(MeOH/EtOAc: 1/1) 0.43; IR ν (KBr) 3325, 3299 (N–H, O–H), 1687 (C=O), 1044, 
1024 (C–O) cm-1; 1H NMR (CD3OD) δ 1.79–1.95 (m, 3 H, 2 × CH2CH2NH, 1 × 
CH2CHCO), 2.21–2.39 (m, 1 H, CH2CHCO), 3.09–3.39 (m, 2 H, CH2NH), 3.62–3.64 
(m, 1 H, CHCO), 5.26 (d, J = 6.5 Hz, 1 H, CHOH), 5.45 (d, J = 6.5 Hz, 1 H, PhCHNH), 
7.56 (br s, 10 H, ArH) ppm; 13C NMR δ 26.9 (CH2CH2NH), 31.8 CH2CHCO), 47.9 
(CH2NH), 59.7 (NCHPh), 61.5 (NCHCO), 77.4 (OCHPh), 128.1, 128.3, 128.6, 128.96, 
128.99, 129.1, 129.2 (ArCH), 140.6, 142.7 (ArC), 176.6 (C=O) ppm; MS m/z 292 [M+ – 
H2O, 5%], 290 (39), 288 (15), 281 (14), 208 (11), 207 (45), 201 (35), 196 (11), 195 
(11), 194 (28), 180 (61), 184 (51), 183 (75), 181 (13), 179 (24), 178 (23), 165 (23), 156 
(21), 130 (10), 129 (11), 117 (19), 116 (12), 106 (11), 105 (19), 104 (19), 91 (24), 90 
(20), 89 (29), 77 (23), 70 (100); HRMS calcd. for C19H22N2O2 [M+] 310.1681, found 
310.1661. 
(2S)-N-[(R)-2-Hydroxy-1-phenylethyl]pyrrolidine-2-carboxamide (21c). White 
solid; M.p. 125 ºC (EtOH/hexane); [ ]20Dα –86.9 (c 1.0, CH2Cl2); Rf (MeOH/EtOAc: 1/1) 
0.50; IR ν (KBr) 3306 (N–H, O–H), 1648 (C=O), 1077, 1062 (C–O) cm-1; 1H NMR 
(CD3OD) δ 1.67–1.84 (m, 2 H, CH2CH2NH), 1.87–1.98 (m, 1 H, CH2CHCO), 2.01–
2.22 (m, 1 H, CH2CHCO), 2.91–3.04 (m, 2 H, CH2NH), 3.43 (br s, 2 H, OH, NH), 
3.77–3.82 (m, 3 H, 2 × CH2OH, 1 × CHCO), 4.97–5.03 (m, 1 H, PhCH), 7.25–7.37 (m, 
5 H, ArH), 8.30 (d, J = 7.8 Hz, 1 H, NHCO) ppm; 13C NMR δ 26.0 (CH2CH2NH), 30.8 
(CH2CHCO), 47.1 (CH2NH), 56.1 (CHPh), 60.4 (CHCO), 66.8 (CH2OH), 126.6, 127.7, 
128.7 (ArCH), 139.0 (ArC), 175.5 (C=O) ppm; MS m/z 216 [M+ – H2O, 28%], 214 
(23), 206 (19), 201 (19), 199 (17), 198 (25), 184 (16), 183 (30), 174 (59), 160 (60), 156 
(10), 120 (72), 119 (27), 118 (17), 117 (13), 105 (17), 104 (100), 103 (26), 96 (10), 91 
(27), 90 (16), 89 (22), 83 (11), 78 (14), 77 (22), 70 (52), 69 (14), 68 (24), 55 (10), 51 
(10); C13H18N2O2 (234.29): calcd. C 66.64, H 7.74, N 11.96, O 13.66; found C 66.65, H 
7.94, N 11.84. 
(S)-N-(2-Hydroxyphenyl)pyrrolidine-2-carboxamide (21d). Yellow solid; M.p. 170 
ºC (EtOH, ∆); [ ]20Dα –45.6 (c 1.0, CH2Cl2); Rf (EtOAc) 0.22; IR ν (KBr) 3220, 3357 (N–
H, O–H), 1641 (C=O), 1092 (C–O) cm-1; 1H NMR (DMSO) δ 1.56–1.65 (m, 2 H, 
CH2CH2NH), 1.73–1.84 (m, 1 H, CH2CHCO), 1.97–2.09 (m, 1 H, CH2CHCO), 2.71–
2.79 (m, 1 H, CH2NH), 2.90–2.98 (m, 1 H, CH2NH), 3.7 (dd, J = 5.2, 8.9 Hz, 1 H, 
CHCO), 6.71–6.86 (m, 4 H, ArH), 8.17 (d, J = 7.96 Hz, 1 H, NHCO) ppm; 13C NMR 
(DMSO) δ 26.0, (CH2CH2NH), 30.3 (CH2CHCO), 46.6 (CH2NH), 60.8 (CHCO), 114.5, 
118.6, 119.0, 123.2 (ArCH), 126.3 (NHC), 146.0 (COH), 173.0, (C=O) ppm; MS m/z 
206 [M+, 2%], 70 (100); HRMS calcd. for C11H14N2O2 [M+] 206.1055, found 206,1064.  
(2S)-N-[(1S,2R)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]pyrrolidine-2-carboxamide 
(21e). White solid, M.p. 169 ºC (EtOAc/MeOH, ∆); [ ]20Dα –24.6 (c 1.0, CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.61; IR ν (KBr) 3336, 3295 (N–H, O–H), 1633 (C=O), 1066, 
1090 (C–O) cm-1; 1H NMR δ 1.63–1.83 (m, 2 H, CH2CH2NH), 1.93–2.03 (m, 1 H, 
CH2CHCO), 2.12–2.21 (m, 1 H, CH2CHCO), 2.54 (br s, 1 H, OH), 2.81–2.98 (m, 3 H, 1 
× CH2CHOH, 2 × CH2NH), 3.14 (dd, J = 16.5, 5.1 Hz, 1 H, CH2CHOH), 3.77 (dd, J = 
9.0, 5.3 Hz, 1 H, CHCO), 4.61 (dt, J = 5.1, 2.3 Hz, 1 H, CHOH), 5.31 (dd, J = 8.7, 4.9 
Hz, 1 H, NCHCH), 7.14–7.26 (m, 4 H, ArH), 8.13 (d, J = 8.5 Hz, 1 H, NHCO) ppm; 
13C NMR δ 26.2 (CH2CH2NH), 31.1 (CH2CHCO), 39.6 (CH2CHOH), 47.2 (CH2NH), 
57.0 (CHCHNH), 60.7 (CHCO), 73.6 (CHOH), 124.1, 125.3, 127.0, 128.1 (ArCH), 
140.2, 140.8 (ArC), 176.2 (C=O) ppm; MS m/z 228 [M+ – H2O, 33%], 211 (11), 210 
(13), 186 (69), 173 (63), 133 (12), 132 (39), 131 (12), 130 (11), 117 (13), 116 (100), 
115 (84), 103 (11), 85 (29), 77 (10), 70 (34), 68 (12); C14H18N2O2 (246.30): calcd. C 
68.27, H 7.37, N 11.37, O 12.99; found C 68.37, H 7.47, N 11.72. 
(2S)-N-[(R)-2,3-Dihydro-1H-inden-1-yl]pyrrolidine-2-carboxamide (21f). Yellow 
oil; Rf (EtOAc/MeOH: 2/1) 0.36; [ ]20Dα +23.4 (c 1.0, CH2Cl2); IR ν (neat) 3294 (N–H), 
1654 (C=O) cm-1; 1H NMR δ 1.67–1.85 (m, 3 H, 2 × CH2CH2NH, 1 × CH2CH2C), 
1.97–2.26 (m, 3 H, 2 × CH2CHCO, 1 × CH2NH), 2.54–2.64 (m, 1 H, CH2CH2C), 2.81–
3.03 (m, 4 H, 2 × CH2CH2C, 2 × CH2NH), 3.80 (dd, J = 9.2, 5.2 Hz, 1 H, CHCO), 5.46 
(dd, J = 16.7, 8.3 Hz, 1 H, CHNHCO), 7.17–7.26 (m, 4 H, ArH), 7.88 (d, J = 8.11 Hz, 1 
H, NHCO) ppm; 13C NMR δ 26.2 (CH2CH2NH), 30.2 (CH2CH2C), 31.1 (CH2CHCO), 
34.1 (CH2CH2C), 47.2 (CH2NH), 53.8 (CHNHCO), 60.5 (CHCO), 123.7, 124.7, 126.7, 
127.7 (ArCH), 143.2, 143.6 (ArC), 175.2 (C=O) ppm; MS m/z 230 [M+, <1%], 115 
(10), 70 (100); HRMS calcd. for C14H18N2O [M+] 230.1419, found 230.1430. 
(2S,4R)-N-[(1S,2R)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]-4-hydroxypyrrolidine-
2-carboxamide (21g). Pale yellow solid; M.p. 142 ºC (EtOAc, ∆); Rf (EtOAc/MeOH: 
2/1) 0.41; [ ]20Dα +15.3 (c 1.0, MeOH); IR ν (KBr) 3358, 3323 (N–H, O–H), 1651 (C=O), 
1097, 1060, 1039 (C–O); 1H NMR (CD3OD) δ 1.78–1.86 (m, 1 H, CH2CHCO), 2.10–
2.17 (m, 1 H, CH2CHCO), 2.76–2.81 (m, 3 H, 2 × CH2NH, 1 × CHCH2C), 3.02 (dd, J = 
16.4, 5.0 Hz, 1 H, CHCH2C), 3.89 (t, J = 16.7 Hz, 1 H, CHCO), 4.24 (br d, J = 2.5 , 1 
H, CH2CHCH2), 4.41 (dt, J = 5.0, 1.3 Hz, 1 H, CH2CHCH), 5.12 (d, J = 5.0 Hz, 1 H, 
CHCHNH), 7.01–7.13 (m, 4 H, ArH) ppm; 13C NMR δ 40.7 (CH2NH), 41.0 
(CHCH2CH), 55.9 (CHCH2C), 58.1 (CHCHNH), 60.8 (CH2CHCO), 73.6 (CHOH), 74 
(CHOH), 124.8, 126.2, 127.8, 128.9 (ArCH), 141.7, 142.3 (ArC), 177.7 (C=O) ppm; 
MS m/z 244 [M+ – H2O, <1%], 216 (24), 215 (19), 211 (24), 210 (37), 201 (10), 188 
(26), 187 (75), 186 (64), 133 (20), 132 (21), 131 (11), 117 (13), 116 (100), 115 (81), 87 
(13), 86 (34), 85 (28); HRMS calcd. for C14H18N2O3 [M+] 262.1317, [M+–17] 245.1296, 
found 245.1293. 
(2S,4R)-4-(tert-Butyldimethylsilyloxy)-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-
inden-1-yl]-pyrrolidine-2-carboxamide (21h). White solid; M.p. 138–140 ºC 
(EtOAc); [ ]20Dα +8.5 (c 0.65, MeOH); Rf (EtOAc) 0.36; IR ν (KBr) 3408, 3290 (N–H, 
O–H), 1655 (C=O), 1090, 1053, (C–O); 1H NMR δ 0.06, 0.08 [2s, 6 H, (CH3)2], 0.87 [s, 
9 H, C(CH3)3], 1.92–2.04 (m, 1 H, CH2CHCO), 2.24–2.32 (m, 1 H, CH2CHCO), 2.45 
(br s, 2 H, OH, CONH), 2.72–2.77 (m, 1 H, CH2N), 2.85–2.89 (m, 1 H, CH2N), 2.93–
2.99 (m, 1 H, CH2CHOH), 3.13–3.20 (m, 1 H, CH2CHOH), 4.05 (t, J = 8.3 Hz, 1 H, 
CHCO), 4.38 (br s, 1 H, OH), 4.63–4.67 (m, 1 H, CHOH), 5.33 (dd, J = 8.6, 5.1 Hz, 1 
H, CHCHN), 7.14–7.26 (m, 4 H, ArH), 8.20 (d, J = 8.4 Hz, 1 H, NHCO) ppm; 13C 
NMR δ –4.8, –4.7 [Si(CH3)2], 18.0 [C(CH3)3], 25.7, 25.8 [C(CH3)3], 39.6 (CH2N), 40.4 
(CH2CHCO), 55.9 (CH2CHOH), 57.0 (CHCHN), 59.9 (CHCO), 73.6 (CHOH), 73.9 
(CHOTBDMS), 124.2, 125.4, 127.1, 128.2 (ArCH), 140.2, 140.7 (ArC), 175.9 (C=O) 
ppm; MS m/z 358 [M+ – H2O, 8%], 302 (13), 301 (54), 226 (12), 210 (46), 201 (14), 
200 (100), 186 (19), 173 (20), 132 (11), 131 (12), 117 (11), 116 (90), 115 (42), 81 (70), 
75 (15), 73 (17), 68 (11); HRMS calcd. for C20H32N2O3Si [M+] 376.2182, [M+ – H2O] 
358.2088, found 358.2083. 
(2S)-N-[(1S,2R)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]-N-methylpyrrolidine-2-
carboxamide (21i). Yellow solid; M.p. 156–158 ºC (EtOAc/hexane); [ ]20Dα –29.0 (c 1.0, 
CH2Cl2); Rf (MeOH) 0.27; IR ν (KBr) 3249, 3065 (N–H, O–H), 1628 (C=O), 1100 (C–
O) cm-1; 1H NMR (rotamers mixture) δ 1.72–2.27 (m, 8 H, 4 × CH2CH2N, 4 × 
CH2CHCO), 2.62 (s, 3 H, CH3), 2.73 (s, 3 H, CH3) 2.80–3.09 (m, 4 H, 2 × CH2CHOH, 
2 × CH2N), 3.97 (dd, J = 9.1, 6.3 Hz, 1 H, CHCO), 4.31 (t, J = 7.2 Hz, 1 H, CHCO), 
4.76 (m, 2 H, CHOH), 5.30 (d, J = 7.0 Hz, 1 H, NCHCH) 5.85 (d, J = 6.9 Hz, 1 H, 
NCHCH), 7.19–7.35 (m, 8 H, ArH) ppm; 13C NMR δ 26.5, 26.6 (CH2CH2N), 30.0, 30.1 
(CH2CHCO), 31.3, 32.1 (CH3), 39.9, 40.1 (CH2CHOH), 47.1, 47.8 (CH2N), 58.2, 58.8 
(CHCHN), 61.5, 63.5 (CHCO), 71.8, 72.4 (CHOH), 125.2, 125.4, 125.6, 125.9, 127.2, 
128.7, 128.9, (ArCH), 138.0, 138.2, 141.3, 141.6 (ArC), 173.8, 176.1 (C=O) ppm; MS 
m/z 242 [M+ – H2O, 7%], 175 (10), 174 (81), 146 (10), 145 (13), 144 (16), 133 (17), 117 
(13), 116 (78), 115 (100), 98 (16); HRMS calcd. for C15H20N2O2 [M+], 260.1525, [M+ – 
H2O] 242.1408, found 242.1411. 
(2S)-N-[(1R,2R)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]pyrrolidine-2-carboxamide 
(21j). White solid; M.p. 165 ºC (EtOAc, ∆); [ ]20Dα +78.8 (c 1.0, CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.31; IR ν (KBr) 3384, 3292 (N–H, O–H), 1659 (C=O), 1080 (C–
O) cm-1; 1H NMR δ 1.67–1.76 (m, 2 H, CH2CH2N), 1.93–2.05 (m, 1 H, CH2CHCO), 
2.13–2.26 (m, 1 H, CH2CHCO), 2.50–3.50 (br s, 1 H, OH), 2.82–3.06 (m, 3 H, 1 × 
CH2CHOH, 2 × CH2N), 3.29 (dd, J = 15.8, 7.6 Hz, 1 H, CH2CHOH), 3.85 (dd, J = 8.9, 
5.2 Hz, 1 H, CHCO), 4.36 (dd, J = 15.1, 7.6 Hz, 1 H, CHOH), 5.03 (t, J = 5.5 Hz, 1 H, 
NCHCH), 7.22–7.28 (m, 4 H, ArH), 8.29 (br s, 1 H, NHCO) ppm; 13C NMR δ 26.2 
(CH2CH2N), 30.9 (CH2CHN), 38.4 (CH2CHOH), 47.3 (CH2N), 60.3 (CHCHN), 63.4 
(CHCO), 81.7 (CHOH), 122.9, 125.2, 127.2, 128.5 (ArCH), 139.3, 140.6 (ArC), 178.0 
(C=O) ppm; MS m/z 246 [M+, <1%], 70 (100); HRMS calcd. for C14H18N2O2 [M+] 
246.1368, found 246.1359. 
(2S)-N-[(S)-2,3-Dihydro-1H-inden-1-yl]pyrrolidine-2-carboxamide (21k). Yellow 
oil; [ ]20Dα –76.4 (c 1.0, CH2Cl2); Rf (EtOAc/MeOH: 2/1) 0.3; IR ν (neat) 3294 (N–H), 
1656 (C=O) cm-1; 1H NMR δ 1.65–1.82 (m, 3 H, 2 × CH2CH2N, 1 × CH2CH2C), 1.88–
1.99 (m, 1 H, CH2CHCO), 2.10–2.23 (m, 2 H, 1 × CH2NH, 1 × CH2CHCO), 2.53–2.64 
(m, 1 H, CH2CH2C), 2.80–3.03 (m, 4 H, 2 × CCH2CH2, 2 × CH2N), 3.79 (dd, J = 9.0, 
5.3 Hz, 1 H, CHCO), 5.42 (dd, J = 16.1, 7.9 Hz, 1 H, CHNHCO), 7.17–7.27 (m, 4 H, 
ArH), 7.87 (d, J = 7.2 Hz, 1 H, NHCO) ppm; 13C NMR δ 26.1 (CH2CH2CH2), 30.2 
(CH2CH2C), 30.8 (CH2CHCO), 34.2 (CH2CH2C), 47.2 (NCH2), 53.9 (CONHCH), 60.5 
(CHCO), 124.0, 124.7, 126.6, 127.7 (ArCH), 143.3, 143.7 (ArC), 175.2 (C=O) ppm; 
MS m/z 230 [M+, <1%], 115 (10), 70 (100); HRMS calcd. for C14H18N2O [M+] 
230.1419, found 230.1415. 
(2S)-N-[(1R,2S)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]pyrrolidine-2-carboxamide 
(21l). White solid; M.p. 145 ºC (EtOAc/MeOH); [ ]20Dα –6.9 (c 1.0, CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.27; IR ν (KBr) 3302, 3190 (N–H, O–H), 1645 (C=O), 1055 (C–
O) cm-1; 1H NMR δ 1.61–1.82 (m, 2 H, CH2CH2N), 1.89–2.03 (m, 1 H, CH2CHN), 
2.08–2.20 (m, 1 H, CH2CHN), 2.85 (br s, 1 H, OH), 2.88–2.96 (m, 3 H, 1 × CH2CHOH, 
2 × CH2CH2N), 3.13 (dd, J = 16.4, 5.1 Hz, 1 H, CH2CHOH), 3.76 (dd, J = 8.7, 5.6 Hz, 
1 H, CHCO), 4.59 (dt, J = 5.4, 2.9 Hz, 1 H, CHOH), 5.27 (dd, J = 8.3, 5.2 Hz, 1 H, 
NCHCH), 7.22–7.27 (m, 4 H, ArH), 7.93 (d, J = 8.1 Hz, 1 H, NHCO) ppm; 13C NMR δ 
26.2 (CH2CH2N), 31.1 (CH2CHN), 39.6 (CHCH2C), 47.2 (CH2CH2N), 57.3 (CHCHN), 
60.8 (CHCO2), 73.5 (CHOH), 124.5, 125.3, 127.0, 128.2 (ArCH), 140.4, 140.8 (CAr), 
175.9 (C=O) ppm; MS m/z 228 [M+ – H2O, 28%], 210 (13), 207 (11), 186 (69), 198 
(15), 197 (21), 186 (58), 173 (52), 133 (13), 132 (51), 131 (27), 130 (40), 117 (16), 116 
(100), 115 (98), 104 (41), 103 (21), 85 (23), 78 (11), 77 (17), 70 (30), 68 (15). HRMS 
calcd. for C14H18N2O2 [M+] 246.1368, [M+ – H2O] 228.1274, found 228.1248. 
(2S)-N-[(1S,2S)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]pyrrolidine-2-carboxamide 
(21m). White solid; M.p. 149–150 ºC (EtOAc/MeOH, ∆); [ ]20Dα –78.4 (c 1.0, CH2Cl2); 
Rf (MeOH/EtOAc: 1/1) 0.28; IR ν (KBr) 3268, 3073 (N–H, O–H), 1652 (C=O), 1085, 
1064 (C–O) cm-1; 1H NMR δ 1.71–1.89 (m, 2 H, CH2CH2N), 1.95–2.04 (m, 1 H, 
CH2CHN), 2.15–2.28 (m, 1 H, CH2CHN), 1.71–2.04 (br s, 1 H, OH), 2.90–3.11 (m, 3 
H, 1 × CCH2CH, 2 × CH2CH2N), 3.29 (dd, J = 15.7, 7.7 Hz, 1 H, CCH2CH), 3.84 (dd, J 
= 9.0, 5.3 Hz, 1 H, CHCO), 4.39 (dd, J = 15.2, 7.9 Hz, 1 H, CHOH), 5.05 (t, J = 5.5 Hz, 
1 H, NCHCH), 7.15–7.27 (m, 4 H, ArH), 8.25 (br s, 1 H, NHCO) ppm; 13C NMR δ 26.3 
(CH2CH2N), 30.6 (CH2CHN), 38.3 (CHCH2C), 47.2 (CH2CH2N), 60.3 (CHCHN), 63.0 
(CHCO), 81.4 (CHOH), 122.7, 125.1, 127.1, 128.3 (ArCH), 139.4, 140.3 (ArC), 177.6 
(C=O) ppm; MS m/z 246 [M+, <1%], 70 (100); HRMS calcd. for C14H18N2O2 [M+] 
246.1368, found 246.1372.  
(2S)-N-(3-Hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)pyrrolidine-2-
carboxamide (21n). White solid; M.p. 156º C (EtOAc); [ ]20Dα +101.5 (c 0.3 CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.32; IR ν (KBr) 3410, 3312 (N–H, O–H), 1630 (C=O), 1122, 
1099 (C–O) cm-1; 1H NMR δ 0.81 (s, 3 H, CH3CCH3), 0.92 (s, 3 H, CH3CCH3), 1.10 (s, 
3 H, CH2CCH3), 1.04–1.2 (m, 2 H, 1 × CCH2CH2, 1 × CCH2CH2), 1.45–1.53 (m, 1 H, 
CCH2CH2), 1.63–1.80 (m, 3 H, 1 × CCH2CH2, 2 × CH2CH2CH2), 1.87–2.05 (m, 1 H, 
NCHCH2), 2.07–2.21 (m, 4 H, 2 × NCHCH2, 1 × OH, 1 × NHCHCH), 2.87–3.04 (m, 2 
H, CH2NH), 3.67–3.73 (m, 2 H, 1 × NCHCH2, 1 × NCHCH), 3.85 (d, J = 8.1 Hz, 1 H, 
CHOH), 7.98 (br s, 1 H, CONH) ppm; 13C NMR δ 11.2, 20.8, 21.3 (CH3), 26.2, 26.3 
(CCH2CH2, CH2CH2CH2), 31.1 (NCHCH2), 33.4 (CCH2CH2), 47.1 (CH3CCH3), 47.3 
(CH2N), 49.1 (CH2CCH3), 50.1 (CHCH3), 57.9, 60.5 (NHCH), 80.6 (CHOH), 175.5 
(C=O) ppm; MS m/z 266 [M+, <1%], 70 (100); HRMS calcd. for C15H26N2O2 [M+] 
266.1994, [M+ – H2O] 248.1878, found 248.1848. 
(2R)-N-[(1R,2S)-2,3-Dihydro-2-hydroxy-1H-inden-1-yl]pyrrolidine-2-carboxamide 
(ent-21e) White solid; M.p. 169 ºC (EtOAc/MeOH); [ ]20Dα +24.6 (c 1.0, CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.61; IR ν (KBr) 3336, 3295 (N–H, O–H), 1633 (C=O), 1066, 
1090 (C–O) cm-1; 1H NMR δ 1.69–1.86 (m, 2 H, CH2CH2N), 1.97–2.06 (m, 1 H, 
CH2CHN), 2.08–2.28 (m, 1 H, CH2CHN), 1.69–2.28 (br s, 1 H, OH), 2.81–3.05 (m, 3 
H, 1 × CH2CHOH, 2 × CH2CH2N), 3.18 (dd, J = 16.4, 5.2 Hz, 1 H, CH2CHOH), 3.84 
(dd, J = 9.1, 5.2 Hz, 1 H, CHCO), 4.65 (dt, J = 5.1, 2.3 Hz, 1 H, CHOH), 5.34 (dd, J = 
8.7, 5.1 Hz, 1 H, NCHCH), 7.17–7.27 (m, 4 H, ArH), 8.15 (d, J = 7.8 Hz, 1 H, CONH) 
ppm; 13C NMR δ 26.2 (CH2CH2N), 31.1 (CH2CHN), 39.6 (CH2CHOH), 47.2 
(CH2CH2N), 57.0 (NCHCH), 60.7 (CHCO), 73.6 (CHOH), 124.1, 125.3, 127.0, 128.1 
(ArCH), 140.2, 140.9 (ArC), 176.2 (C=O) ppm; MS m/z 228 [M+ – H2O, 34%], 226 
(15), 211 (11), 210 (13), 198 (17), 197 (28), 186 (67), 173 (60), 133 (12), 132 (37), 131 
(26), 130 (38), 117 (13), 116 (100), 115 (94), 104 (44), 103 (21), 85 (26), 77 (16), 70 
(33), 68 (13); HRMS calcd. for C14H18N2O2 [M+] 246.1368, found 246.1361. 
(2S)-2-amino-N-((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)propanamide (23). 
Pale yellow solid; M.p. 143–144 ºC (EtOAc); [ ]20Dα +34.0 (c 1.0, CH2Cl2); Rf 
(MeOH/EtOAc: 1/1) 0.45; IR ν (KBr) 3295 (N–H, O–H), 1641 (C=O), 1054, 1086 (C–
O) cm-1; 1H NMR (400Mz) δ 1.37 (d, J = 6.8 Hz, 3 H, CH3), 2.21 (br s, 3 H, 2 × NH2, 1 
× OH), 2.92 (dd, J = 16.4, 1.8 Hz, 1 H, CH2), 3.14 (dd, J = 16.4, 5.3 Hz, 1 H, CH2), 3.53 
(q, J = 6.8 Hz, 1 H, CHCH3), 4.58 (dt, J = 5.2, 2.5 Hz, 1 H, CHOH), 5.29 (dd, J = 8.5, 
5.2 Hz, 1 H, CHNH), 7.21–7.27 (m, 4 H, ArH), 7.75 (d, J = 8.1 Hz, 1 H, NHCO) ppm; 
13C NMR δ 21.8 (CH3), 39.6 (CH2), 50.9 (CHNH2), 57.1 (CHNH), 73.5 (CHOH), 
124.3, 125.2, 127.0, 128.1 (ArCH), 140.2, 140.7 (ArC), 176.6 (C=O) ppm; MS m/z 202 
[M+ – H2O, 24%], 188 (13), 187 (99), 133 (12), 132 (22), 116 (68), 115 (100), 103 (10); 
HRMS calcd. for C12H16N2O2 [M+] 220.1212 found 220.1219. 
Typical procedure for the Michael addition of ketones to β-nitrostyrenes. A 
mixture of catalyst 21 (0.08 mmol), 4-nitrobenzoic acid (0.08 mmol) and the 
corresponding ketone (4 mmol) in NMP (0.2 ml) was stirred for 20 min at 25 ºC. Then, 
the corresponding nitrostyrene (0.4 mmol) was added to the mixture and the reaction 
was stirred at 25 ºC for the reaction time stated in Tables. The reaction mixture was 
quenched with water (2 mL) and extracted with EtOAc (3 × 2 mL). The organic layers 
were washed with water (3 × 2 mL) in order to remove NMP, dried over anhydrous 
MgSO4, filtered off and the solvent was evaporated at low pressure to give crude 
products which were purified by flash chromatography (hexane/EtOAc: 18/1, 3.5 
mL/min) giving pure syn-27.  
Compounds 27aa,[7] 27ba,[11] 27ca,[8b] 27da,[8a] have been previously described and 
spectroscopic data were in agreement with published. See supporting information for 
HPLC separation conditions.  
syn-4-Methyl-6-nitro-5-p-tolylhexan-3-one (27ab). Colourless oil; [ ]20Dα  +14.8 (c 1.0, 
CH2Cl2) for 74% ee; Rf (Hexane/EtOAc: 5/1) 0.39; IR ν (neat) 1552 (NO2), 1704 
(C=O) cm-1; 1H NMR (400 MHz) δ  0.96 (d, J = 7.3 Hz, 3 H, CH3CH), 1.07 (t, J = 7.3 
Hz, 3 H, CH3CH2), 2.31 (s, 3 H, CH3Ar), 2.41 (dq, J = 18.2, 7.3 Hz, 1 H, CH2CH3), 
2.61 (dq, J = 17.9, 7.1 Hz, 1 H, CH2CH3), 2.93–3.00 (m, 1 H, CHCH3), 3.65 (dt, J = 9.3, 
5.0 Hz, 1 H, CHAr), 4.57 (dd, J = 12.4, 4.8 Hz, 1 H, CH2NO2), 4.64 (dd, J = 12.4, 9.1 
Hz, 1 H, CH2NO2), 7.04 (d, J = 8.1 Hz, 2 H, ArH), 7.12 (dd, J = 7.8 Hz, 2 H, ArH) 
ppm; 13C NMR δ  7.6 (CH3CH2), 16.2 (CH3CH), 21 (CH3Ar), 35.4 (CH2CO), 45.7 
(CHAr), 48.3 (CHCO), 78.4 (CH2NO2), 127.7, 129.6 (ArCH), 134.4, 137.6 (ArC), 
213.7 (C=O) ppm; MS m/z: 249 [M+, <1%], 202 (13), 187 (17), 173 (67), 146 (13), 145 
(18), 132 (14), 131 (19), 118 (42), 117 (30), 115 (17), 105 (15), 91 (17), 57 (100); 
HRMS calcd. for C14H19NO3 249.1365 [M+], found 249.1356; HPLC (Chiralcel OD-H, 
1mL/min, Hexane/i-PrOH: 99/1, λ 254 nm), tRmaj = 13.3 min, tRmin = 17.7 min. 
syn-5-(4-Chlorophenyl)-4-methyl-6-nitrohexan-3-one (27ac). Colourless oil; 
[ ]20Dα +5.7 (c 1.0, CH2Cl2) for 78% ee; Rf (Hexane/EtOAc: 5/1) 0.2; IR ν  (neat.) 1553 
(NO2), 1711 (C=O) cm–1; 1H NMR (400 MHz) δ  0.96 (d, J = 7.1 Hz, 3 H, CH3CH), 
1.07 (t, J = 7.1 Hz, 3 H, CH3CH2), 2.41 (dq, J = 17.9, 7.1 Hz, 1 H, CH2CH3), 2.62 (dq, J 
= 17.9, 7.1 Hz, 1 H, CH2CH3), 2.95 (dq, J = 9.3, 7.2 Hz, 1 H, CHCH3), 3.69 (dt, J = 9.3, 
4.9 Hz, 1 H, CHAr), 4.58 (dd, J = 12.4, 4.8 Hz, 1 H, CH2NO2), 4.64 (dd, J = 12.4, 9.0 
Hz, 1 H, CH2NO2), 7.11 (d, J = 8.3 Hz, 2 H, ArH), 7.31 (dd, J = 6.6 Hz, 2 H, ArH) 
ppm; 13C NMR δ  7.6 (CH3CH2), 16.2 (CH3CH), 35.4 (CH2CO), 45.4 (CHAr), 48.1 
(CHCO), 78.0 (CH2NO2), 129.2, 129.3 (ArCH), 133.8, 136.0 (ArC), 213.1 (C=O) ppm; 
MS m/z: 269 [M+ – CH3CH2, <1%], 193 (19), 138 (18), 115 (10), 57 (100); HRMS 
calcd. for C13H16ClNO3 [M+] 269.0819, [M+ – NO2] 223.0884, found 223.0874; HPLC 
(Chiralcel OD-H, 1mL/min, Hexane/i-PrOH: 99/1, λ 254 nm), tRmaj = 22.6 min, tRmin = 
25.8 min. 
syn-5-(4-Methoxyphenyl)-4-methyl-6-nitrohexan-3-one (27ad). White solid; M.p. 
124 ºC (EtOAc/pentane); [ ]20Dα –10.1 (c 1.0, CH2Cl2) for 73% ee; Rf (Hexane/EtOAc: 
5/1) 0.29; IR ν  (KBr) 1245 (Ar–O–C), 1552 (NO2), 1705 (C=O) cm–1; 1H NMR δ  
1.38 (d, J = 7.2 Hz, 3 H, CH3CH), 1.48 (t, J = 7.3 Hz, 3 H, CH3CH2), 2.83 (dq, J = 18.0, 
7.2 Hz, 1 H, CH2CH3), 3.03 (dq, J = 18.1, 7.2 Hz, 1 H, CH2CH3), 3.37 (dq, J = 9.5, 7.2 
Hz, 1 H, CHCH3), 4.06 (dt, J = 9.0, 5.1 Hz, 1 H, CHAr), 4.2 (s, 3 H, OCH3) 4.95–5.08 
(m, 2 H, CH2NO2), 7.27 (d, J = 8.6 Hz, 2 H, ArH), 7.49 (d, J = 8.6 Hz, 2 H, ArH) ppm; 
13C NMR δ  7.6 (CH3CH2), 16.2 (CH3CH), 35.4 (CH2CO), 45.3 (CHAr), 48.5 (CHCO) 
55.2 (OCH3), 78.5 (CH2NO2), 114.3, 128.9 (ArCH), 129.4, 159.1 (ArC), 213.7 (C=O) 
ppm; MS m/z 265 [M+, 4%], 218 (26), 203 (17), 189 (52), 162 (11), 161 (10), 135 (13), 
134 (100), 121 (10), 119 (11), 91 (14), 57 (77); C14H19NO4 (265.31): calcd. C 63.38, H 
7.22, N 5.28, O 24.12; found C 63.26, H 7.34, N 5.27; HPLC (Chiralcel OD-H, 
1mL/min, Hexane/i-PrOH: 99/1, λ 254 nm), tRmaj = 21.4 min, tRmin = 27.4 min. 
syn-5-(3,5-Dichlorophenyl)-4-methyl-6-nitrohexan-3-one (27ae). Yellow oil; [ ]20Dα –
24.4 (c 1.0, CH2Cl2) for 72% ee; Rf (Hexane/EtOAc: 5/1) 0.31; IR ν (neat) 1556 (NO2), 
1712 (C=O) cm–1; 1H NMR δ  1.02 (d, J = 7.2 Hz, 3 H, CH3CH), 1.06 (t, J = 7.2 Hz, 3 
H, CH3CH2), 2.39 (dq, J = 18.1, 7.2 Hz, 1 H, CH2CH3), 2.64 (dq, J = 18.1, 7.2 Hz, 1 H, 
CH2CH3), 3.10–3.20 (m, 1 H, CHCH3), 4.24 (dt, J = 9.0, 4.2 Hz, 1 H, CHAr), 4.61 (dd, 
J = 12.8, 4.2 Hz, 1 H, CH2NO2), 4.82 (dd, J = 12.8, 8.7 Hz, 1 H, CH2NO2), 7.11 (d, J = 
8.4 Hz, 1 H, ArH), 7.22–7.27 (m, 1 H, ArH), 7.44 (d, J = 2.2 Hz, 1 H, ArH) ppm; 13C 
NMR δ  7.6 (CH3CH2), 16.1 (CH3CH), 35.5 (CH2CO), 41.7 (CHAr), 46.8 (CHCO), 
76.4 (CH2NO2), 127.7, 129.4, 130.2 (ArCH), 133.8, 134.2, 135.2 (ArC), 213.0 (C=O) 
ppm; MS m/z: 303 [M+, <1%], 261 (14), 199 (11), 186 (11), 172 (11), 57 (100); HRMS 
calcd. for C13H15Cl2NO3 [M+] 303.0429, found 303.0421; HPLC (Chiralcel OD-H, 
1mL/min, Hexane/i-PrOH: 99/1, λ 254 nm), tRmaj = 13.9 min, tRmin = 17 min. 
syn-4-Methyl-6-nitro-5-[2-(trifluoromethyl)phenyl]hexan-3-one (27af). Yellow oil; 
[ ]20Dα –4.5 (c 1.0, CH2Cl2) for 50% ee; Rf (Hexane/EtOAc: 5/1) 0.25; IR ν  (neat) 1556 
(NO2), 1713 (C=O) cm–1; 1H NMR δ  0.97 (d, J = 7.2 Hz, 3 H, CH3CH), 1.09 (t, J = 7.3 
Hz, 3 H, CH3CH2), 2.48 (dq, J = 18.1, 7.3 Hz, 1 H, CH2CH3), 2.67 (dq, J = 18.1, 7.2 Hz, 
1 H, CH2CH3), 3.21–3.31 (m, 1 H, CHCH3), 4.06–4.15 (m, 1 H, CHAr), 4.58 (dd, J = 
11.8, 4.0 Hz, 1 H, CH2NO2), 4.82 (dd, J = 11.8, 6.7 Hz, 1 H, CH2NO2), 7.28 (d, J = 7.8 
Hz, 1 H, ArH), 7.41 (t, J = 7.6 Hz, 1 H, ArH), 7.54 (t, J = 7.5 Hz, 1 H, ArH), 7.72 (d, J 
= 7.8 Hz, 1 H, ArH) ppm; 13C NMR δ  7.5 (CH3CH2), 16.4 (CH3CH), 35.4 (CH2CO), 
40.8 (CHAr), 47.7 (CHCO), 77.9 (CH2NO2), 122.3 (CF3), 125.9 (ArC), 126.7, 127.8 
(ArCH), 129.3 (ArC), 132.4 (ArCH), 136.8 (ArC), 213.3 (C=O) ppm; MS m/z: 303 [M+ 
– CH3CH2, <3%], 199 (42), 186 (17), 178 (11), 159 (13), 151 (10), 57 (100); HRMS 
calcd. for C14H16F3NO3 [M+] 303.1082, [M+ – CH3CH2] 274.0686, found 274.0710. 
HPLC (Chiralcel OD-H, 1mL/min, Hexane/i-PrOH: 99/1, λ 254 nm), tRmaj = 8.8 min, 
tRmin = 11.5 min. 
syn-5-(2-Chlorophenyl)-4-methyl-6-nitrohexan-3-one (27ag). Colourless oil; 
[ ]20Dα +21.5 (c 1.0, CH2Cl2) for 78% ee; Rf (Hexane/EtOAc: 5/1) 0.4; IR ν  (neat.) 1557 
(NO2), 1713 (C=O) cm–1; 1H NMR (400 MHz) δ  1.02 (d, J = 7.2 Hz, 3 H, CH3CH), 
1.06 (t, J = 7.2 Hz, 3 H, CH3CH2), 2.38 (dq, J = 17.9, 7.2 Hz, 1 H, CH2CH3), 2.62 (dq, J 
= 17.9, 7.2 Hz, 1 H, CH2CH3), 3.16–3.24 (m, 1 H, CHCH3), 4.30 (dt, J = 9.2, 4.4 Hz, 1 
H, CHAr), 4.63 (dd, J = 12.7, 4.4 Hz, 1 H, CH2NO2), 4.85 (dd, J = 12.7, 8.8 Hz, 1 H, 
CH2NO2), 7.15–7.27 (m, 3 H, ArH), 7.41 (d, J = 9.4 Hz, 1 H, ArH) ppm; 13C NMR δ  
7.6 (CH3CH2), 16.1 (CH3CH), 35.5 (CH2CO), 42.1 (ArCH), 46.9 (CHCO), 76.6 
(CH2NO2), 127.3, 128.9, 128.5, 130.4 (ArCH), 134.5, 135.1 (ArC), 213.3 (C=O) ppm; 
MS m/z: 234 [M+– Cl, 54%], 167 (11), 165 (30), 152 (22), 138 (13), 131 (10), 130 (15), 
129 (12), 125 (15), 115 (17), 103 (14), 57 (100); HRMS calcd. for C13H16ClNO3 [M+] 
269.0819, [M+ – Cl] 234.1125, found 234.1151; HPLC (Chiralcel OD-H, 1mL/min, 
Hexano/i-PrOH: 99/1, λ 210 nm), tRmaj = 11.2 min, tRmin = 14.3 min. 
4-Methyl-5-nitro-6-phenylhexan-3-one (31). Yellow oil; Rf  (hexano/EtOAc: 6/1) 
0.49; IR ν  (neat.) 1558 (NO2), 1714 (C=O) cm–1; 1H NMR δ  1.06 (t, J = 7.3 Hz, 3 H, 
CH3CH2), 1.18 (d, J = 7.0 Hz, 3 H, CH3CH), 2.30–2.46 (m, 3 H, 2 × CH2Ph, 1 × 
CHCH3), 2.50–2.68 (m, 2 H, CH2CH3), 5.45 (t, J = 7.64 Hz, 1 H, CHNO2), 7.36–7.47 
(m, 5 H, ArH) ppm; 13C NMR δ  7.7 (CH3CH2), 17.8 (CH3CH), 34.8 (CH2), 36.5 
(CH2), 42.6 (CHCO), 89.8 (CH2NO2), 127.6, 129.0, 129.9 (ArCH), 134.3 (ArC), 213.4 
(C=O) ppm; MS m/z 207 [M+ – H2O, <1%], 189 (46), 131 (58), 117 (14), 115 (2), 114 
(11), 91 (13), 57 (34). HRMS calcd. for C13H17NO3 [M+] 235.1208, [M+ – NO2] 
189.1274, found 189.1265. 
 
Supporting Information (see footnote on the first page of this article): typical 
procedure for the Michael addition under microwave irradiation and solvent screening 
for the Michael addition of ketones 25b, 25c, and 25d to β-nitrostyrene. Typical 
procedure for recovery of catalyst 21e and ESI-MS (+) experiments and spectra. 
Cartesians coordinates for transition states and reactant complexes and HPLC 
separation conditions are included. 
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